Secretoneurin gene therapy improves blood flow in an ischemia model in type 1 diabetic mice by enhancing therapeutic neovascularization.
Schgoer, Wilfried
Secretoneurin gene therapy improves blood flow in an ischemia model in type 1 diabetic mice by enhancing therapeutic neovascularization. [electronic resource] - PloS one 2013 - e74029 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1932-6203
10.1371/journal.pone.0074029 doi
Animals
Cells, Cultured
Diabetes Mellitus, Experimental--complications
Diabetes Mellitus, Type 1--complications
Endothelium, Vascular--cytology
Genetic Therapy
Humans
Ischemia--complications
Mice
Neovascularization, Physiologic
Neuropeptides--genetics
Regional Blood Flow
Secretogranin II--genetics
Streptozocin
Secretoneurin gene therapy improves blood flow in an ischemia model in type 1 diabetic mice by enhancing therapeutic neovascularization. [electronic resource] - PloS one 2013 - e74029 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1932-6203
10.1371/journal.pone.0074029 doi
Animals
Cells, Cultured
Diabetes Mellitus, Experimental--complications
Diabetes Mellitus, Type 1--complications
Endothelium, Vascular--cytology
Genetic Therapy
Humans
Ischemia--complications
Mice
Neovascularization, Physiologic
Neuropeptides--genetics
Regional Blood Flow
Secretogranin II--genetics
Streptozocin